2008
In August 2008, a grant of $23,000 was made to The Wesley Institute in Brisbane to conduct a 5 symposia series to the medical community and general public on the topic of asbestosis/mesothelioma. The aim of the symposia was to increase awareness of the disease, its clinical manifestations and the effect on patients and their families.
2007
In November 2007, a grant of $150,000 was made to the Ballarat
Cancer Research Centre to support a two year trial that will
study an individual’s sensitivity and resistance to chemotherapy
protocols for lung and mesothelioma cancer patients. The trial
will determine which chemotherapy treatments best suit an individual
cancer thus improving quality of life and longevity for cancer
patients.
2007
In July 2007, the Slater & Gordon Asbestos Research Fund made
a grant of $60,000 to the Wesley Research Institute in Brisbane
to aid research into asbestos related diseases. The money will
be used to analyse a cohort of patients with asbestos-related
diseases, both benign and malignant.
In March 2007, the Slater & Gordon Asbestos Research Fund made
a grant of $37,700 to St Vincent's Private Hospital, Melbourne.
The money will be used to conduct a project that will assist
in understanding the genetics of lung cancer. As a result of
understanding the genetics of lung cancer "novel" treatments
can be developed to aid in the care of patients such as occurred
with the development of the drug Herceptin for breast cancer
patients.
Also in March 2007, the Slater & Gordon Asbestos Research Fund
made a further grant of $34,230 to St Vincent's Private Hospital,
Melbourne. This money will be used to fund a project that will
develop the hospitals existing lung cancer database so that
it meets DHR requirements and is useable to the other lung cancer
multi-disciplinary cancer clinics in Victoria that have a need
to meet the same requirements. The availability of this data
will assist in generating research ideas from the treatment
of cancer.
2006
In October 2006, the Slater & Gordon Asbestos Research Fund
made a grant of $15,000 to the Perth Mesothelioma Group to enable
them to invite Dr Sam Armato from Chicago to be a guest speaker
at the Third Perth Mesothelioma Centre Symposium 2006. Dr Armato
is an Associate Professor of Radiology and the Committee on
Medical Physics at the University of Chicago. He is an expert
in the CT scanning of mesothelioma.
In September 2006 the Slater & Gordon Asbestos Research Fund
made a grant of $57,605 to Austin Health to enable them to synthesise
and formulate a drug known as Haematoporphyrin derivative (HPD)
for use in the treatment of patients with mesotheliomna.
In June 2006, the Slater & Gordon Asbestos Research Fund made
a grant of $1,000 to the Australian Society of Cytology. The
grant covered sponsorship of the session entitled "An update
on the diagnosis and management of mesothelioma".
2005
In September 2005, the Slater & Gordon Asbestos Research Fund
supported Gippsland Rotary Centenary House with a grant of $25,000
to build a community owned accommodation facility for patients
attending the Gippsland Cancer Care Centre at the Latrobe Regional
Hospital.
2004
In March 2004, The Slater & Gordon Asbestos Research Fund awarded
$50,000 to Professor Bill Musk to support continuing fundamental
research into the Wittenoom cohort.
-
ALF Awards
2008
Awarded to Professor Paul Reynolds to conduct a project entitled "Pre clinical evaluation of Conditionally Replicative Adenovirus Ad5/3Delat24 as a therapy for mesothelioma."
2007
Awarded to Professor Paul Reynolds to
conduct a project entitled " Does replicative viral therapy
synergize with immunotherapy in mesothelioma?"
2006
Awarded to Dr Robbert van der Most to
conduct a project entitled "Can we improve anti-mesothelioma
chemotherapy by immunotherapy: the promise of interleukin-12"
2005
Awarded to Professor Bruce Robinson to conduct a project entitled
"How the body recognises mesothelioma antigens and how to modify
them to produce new therapies"
2008
Mr Svien Van Oyen was awarded $4,270 to attend the International Mesothelioma Interest Group Meeting in the Netherlands in September 2008
Ms Alison Reid was awarded $4,231 to attend the International Mesothelioma Interest Group Meeting in the Netherlands in September 2008
Dr Helman Alfonso was awarded $4,200 to attend the International Mesothelioma Interest Group Meeting in the Netherlands in September 2008
2007
Dr Penny Wong was awarded a $3,000 fellowship to
attend the TSANZ conference in New Zealand in March 2007.
2006
Dr Greg Deleuil was awarded a $4,000 fellowship to attend
the Asian Asbestos Conference 2006 in Thailand.
Dr Piers Canty was awarded a $5,300 fellowship to attend the
American Thoracic Society International conference in San Diego
from May 19 -24, 2006.
Dr Su W Hii was awarded a $4,700 fellowship to attend the European
Respiratory Society congress in Munich, Germany from September
2-6, 2006.
2005
Ms Natalie Milic, Research Assistant Royal Adelaide Hospital
was awarded a $2,120 fellowship to attend the Thoracic Society
Annual Conference in Perth where she was able to obtain first
hand the latest research information regarding mesothelioma.
The Victorian Asthma Health Educators Assocation (VAHEA)
was awarded a $1,600 fellowship to assist with a professional
development day that included an update on a new assay for the
detection of soluble mesothelin related peptide (SMRP) in serum.
Dr Andrew Kyoong, Advanced Trainee in Respiratory Medicine
at Monash Medical Centre, was awarded a $3,500 fellowship to
attend the European Respiratory Society (ERS) meeting in Copenhagen.
The meeting included core topics and new developments in diagnosis
and treatment of lung cancer, fibrotic lung disease and occupational
lung disease by experts in their field.
2004
Dr Malcolm Feigan was awarded a $5,000 fellowship to visit
the MD Anderson Centre in Houston, Texas to further advance
his research into Intensity Modulated Radiotherapy (IMRT).
Dr James McKeon was awarded a $2,540 fellowship to present
a paper at the 9th Europe Pacific Medical and Legal Conference.
Dr McKeon's paper was entitled "The Medico-Legal Assessment
of Asbestos-Related Lung Disease"
|
